BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 208 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $144,489 | +1.6% | 20,408 | +1.0% | 0.00% | – |
Q2 2023 | $142,271 | -17.5% | 20,209 | -2.3% | 0.00% | – |
Q1 2023 | $172,455 | -99.4% | 20,678 | -99.2% | 0.00% | -100.0% |
Q4 2022 | $29,085,544 | -34.4% | 2,533,584 | -28.0% | 0.03% | -36.5% |
Q3 2022 | $44,355,000 | -8.2% | 3,520,231 | -22.9% | 0.05% | -5.5% |
Q2 2022 | $48,297,000 | -16.1% | 4,564,930 | +28.5% | 0.06% | -5.2% |
Q1 2022 | $57,538,000 | +841.4% | 3,553,521 | +705.3% | 0.06% | +866.7% |
Q4 2021 | $6,112,000 | -8.4% | 441,266 | -4.9% | 0.01% | -14.3% |
Q3 2021 | $6,670,000 | -35.5% | 464,174 | -29.0% | 0.01% | -30.0% |
Q2 2021 | $10,337,000 | +48.3% | 653,829 | -4.6% | 0.01% | +42.9% |
Q1 2021 | $6,971,000 | +1.0% | 685,484 | -26.0% | 0.01% | -12.5% |
Q4 2020 | $6,904,000 | +67.8% | 926,679 | -22.6% | 0.01% | +60.0% |
Q3 2020 | $4,114,000 | +197.7% | 1,197,555 | +313.0% | 0.01% | +150.0% |
Q2 2020 | $1,382,000 | +1282.0% | 289,964 | +484.2% | 0.00% | – |
Q1 2020 | $100,000 | +100.0% | 49,638 | +187.2% | 0.00% | – |
Q3 2019 | $50,000 | – | 17,281 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |